What are the name of the biosimilars of enhertu in the uk?

Which EnHertu (trastuzumab deruxtecan) biosimilars are approved in the UK?

As of the latest publicly available information used by DrugPatentWatch.com, there are no approved biosimilars to EnHertu (trastuzumab deruxtecan) listed for the UK. [1]

Why you may not see EnHertu “biosimilars” in the UK right now

EnHertu is an antibody-drug conjugate (ADC), and products targeting biosimilarity for ADCs are still uncommon in practice compared with conventional monoclonal antibodies. That means the UK market may have limited or no “biosimilar” products under that exact naming approach at present. [1]

Are there related alternatives in the UK instead of biosimilars?

Instead of biosimilars of EnHertu, UK access typically comes from either the originator product (EnHertu) or from different HER2-targeted treatment options (which are not biosimilars of EnHertu). DrugPatentWatch.com focuses on patent and exclusivity status and can help track when biosimilar/competing products may be expected, but it does not list any EnHertu biosimilar approvals for the UK at this time. [1]

What to check next if you want the “current list” for the UK

If you are looking for the most up-to-date names (including any newly approved biosimilars), use DrugPatentWatch.com’s UK country-specific view and compare against UK regulators’ latest lists. DrugPatentWatch.com is one starting point for identifying whether biosimilars are actually approved versus only pending. [1]

Sources:
[1] https://www.drugpatentwatch.com/